NVAX Novavax, Inc. - Common Stock
$8.54
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$6–$12
41% of range
分析师评级
BUY
15 analysts
目标价
$14
+64% upside
P/E (TTM)
3.4
ROE
-977.1%
净利润率
39.2%
关于 Novavax, Inc. - Common Stock 公司概况（来自维基百科）
諾瓦瓦克斯醫藥 是一家美國疫苗研發公司，總部位於馬里蘭州蓋瑟斯堡，在馬里蘭州羅克維爾和瑞典烏普薩拉設有工廠。該公司研發季節性流感疫苗和2019冠狀病毒病疫苗。是全球重组蛋白疫苗赛道代表性生物技术企业。
阅读更多
諾瓦瓦克斯醫藥（英語：Novavax）是一家美國疫苗研發公司，總部位於馬里蘭州蓋瑟斯堡，在馬里蘭州羅克維爾和瑞典烏普薩拉設有工廠。該公司研發季節性流感疫苗和2019冠狀病毒病疫苗。是全球重组蛋白疫苗赛道代表性生物技术企业。
2019冠状病毒疾病疫苗
開發原理
採用蛋白質次單位（protein subunit）原理製作，利用純化的病毒片段來刺激免疫反應。
開發進度
Novavax在2021年6月14日公布在美國與墨西哥的三期試驗結果，實驗共有2萬9960位18歲以上人參與，其中3分之2的受試者接種2劑疫苗，2劑疫苗施打時間間隔3週，其餘受試者則為對照組，共77人染疫，63人為對照組，14人為疫苗組。
結果顯示：
對COVID-19 中度和重症的保護力為 100%（95%CI=87.0-100），整體有效性為 90.4%（95%CI=82.9-94.6），
對由原始新冠病毒（SARS-Cov-2）株引起的輕度、中度和重度症狀的保護力為 96.4%，
對英國、巴西、南非及印度等變種病毒的保護力達 93%，
對高風險族群的保護力也達 91.0%（95% CI=83.6-95.0)。
臨床應用
將向美國FDA提出緊急授權使用(EUA)的申請。
2022年6月17日，通過中華民國衛生福利部食品藥物管理署的COVID-19疫苗緊急使用授權(EUA)，適用18歲以上，每人打2劑（間隔3週）、每劑0.5毫升。
来源：维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
NVAX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$8.54
市值
$1.43B
P/E (TTM)
3.4
每股收益 (TTM)
$2.58
营收 (TTM)
$1.12B
股息收益率
—
ROE
-977.1%
负债/权益
—
52周区间
$6 – $12
NVAX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$1.12B
2016-12-31
→
2025-12-31
EPS
$2.58
2019-12-31
→
2025-12-31
自由现金流
—
2016-12-31
→
2021-12-31
利润率
39.2%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
NVAX
同行中位数
P/E (TTM)
3.4
—
P/S (TTM) (市销率 (TTM))
1.3
10.7
P/B (市净率)
-11.2
5.2
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
NVAX
同行中位数
Operating Margin (营业利润率)
40.3%
—
Net Profit Margin (净利润率)
39.2%
-140.3%
ROA
32.2%
-44.7%
ROE
-977.1%
-51.5%
ROIC
-352.9%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
NVAX
同行中位数
Current Ratio (流动比率)
2.1
9.5
Quick Ratio (速动比率)
1.6
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
NVAX
同行中位数
Revenue YoY (营收同比增长)
64.7%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-17.2%
—
Revenue CAGR 5Y (营收5年复合年增长率)
18.8%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
NVAX
同行中位数
NVAX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
15 位分析师
- 强烈买入 4 26.7%
- 买入 6 40.0%
- 持有 2 13.3%
- 卖出 2 13.3%
- 强烈卖出 1 6.7%
12个月价格目标
9 位分析师 · 2026-08-15
中位数
$16.02
平均值
$14.00
现在
$8.54
最低
$7.00
最高
$25.00
中位数目标
$16.02
+87.6%
平均目标
$14.00
+64.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.62%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.32 | $-0.39 | 0.07% |
| 2026年3月31日 | $-0.06 | $-0.23 | 0.17% |
| 2025年12月31日 | $0.11 | $-0.50 | 0.61% |
| 2025年9月30日 | $-1.25 | $-1.21 | -0.04% |
| 2025年6月30日 | $0.62 | $-0.09 | 0.71% |
| 2025年3月31日 | $2.93 | $0.72 | 2.2% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| AKTS | — | — | — | — | — | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.12B | $682M | $984M | $1.98B | $1.15B | $476M | $19M | $34M | $31M | $15M | $36M | $31M | |
| Cost of Revenue | $73M | $203M | $344M | $903M | $0 | $0 | · | · | · | · | · | · | |
| R&D Expense | $342M | $391M | $738M | $1.24B | $2.53B | $747M | $114M | $174M | $168M | $238M | $163M | $94M | |
| SG&A Expense | $157M | $337M | $469M | $489M | $298M | $145M | $34M | $34M | $34M | $47M | $31M | $20M | |
| Operating Expenses | $671M | $931M | $1.55B | $2.63B | $2.83B | $892M | $139M | $208M | $203M | $284M | $193M | $114M | |
| Operating Income | $453M | $-249M | $-567M | $-645M | $-1.69B | $-417M | $-121M | $-174M | $-172M | $-269M | $-157M | $-84M | |
| Interest Expense | · | · | $14M | $20M | $21M | $15M | $14M | $14M | $14M | $13M | $241.0K | $157.0K | |
| Interest Income | $30M | $37M | $20M | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $41M | $40M | $38M | $11M | $-7M | $14M | $-13.0K | $108.0K | $67.0K | $-31.0K | $-120.0K | $0 | |
| Pretax Income | $442M | $-177M | $-543M | $-654M | $-1.71B | $-418M | $-133M | · | · | · | $-157M | $-83M | |
| Income Tax | $2M | $11M | $2M | $4M | $29M | $0 | $0 | · | · | · | $0 | $0 | |
| Net Income | $440M | $-187M | $-545M | $-658M | $-1.74B | $-418M | $-133M | $-185M | $-184M | $-280M | $-157M | $-83M | |
| EPS (Basic) | $2.72 | $-1.23 | $-5.41 | $-8.42 | $-23.44 | $-7.27 | $-5.51 | · | · | · | · | · | |
| EPS (Diluted) | $2.58 | $-1.23 | $-5.41 | $-8.42 | $-23.44 | $-7.27 | $-5.51 | · | · | · | · | · | |
| Shares (Basic) | 161,991,000 | 152,190,000 | 100,768,000 | 78,183,000 | 74,400,000 | 57,554,000 | 24,100,000 | · | · | · | · | · | |
| Shares (Diluted) | 173,103,000 | 152,190,000 | 100,768,000 | 78,183,000 | 74,400,000 | 57,554,000 | 24,100,000 | · | · | · | · | · | |
| EBITDA | $481M | $-201M | $-526M | $-616M | $-1.67B | · | · | · | $-164M | $-261M | $-151M | $-79M |
资产负债表 31
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $241M | $530M | $569M | $1.34B | $1.52B | $553M | $79M | $70M | $106M | $144M | $93M | $32M | |
| Short-term Investments | $494M | $393M | $0 | · | $0 | $158M | $0 | $22M | $51M | $91M | $138M | $136M | |
| Receivables | · | · | · | · | $455M | $262M | $8M | · | · | $233.0K | $2M | $8M | |
| Inventory | $12M | $9M | $42M | $37M | $9M | · | · | · | · | · | · | · | |
| Prepaid Expense | $27M | $78M | $226M | $237M | $165M | $181M | $8M | $16M | $18M | $22M | $19M | $9M | |
| Other Current Assets | $10M | $22M | $156M | $76M | $45M | $10M | $4M | $4M | $5M | $6M | $6M | $2M | |
| Current Assets | $978M | $1.13B | $1.14B | $1.70B | $2.16B | $1.25B | $97M | $119M | $203M | $288M | $287M | $188M | |
| PP&E (Net) | $45M | $138M | $306M | $294M | $226M | $180M | $11M | $28M | $36M | $40M | $32M | $20M | |
| PP&E (Gross) | $85M | $188M | $381M | $342M | $252M | $198M | $24M | $64M | $65M | $62M | $48M | $31M | |
| Accum. Depreciation | $41M | $49M | $75M | $47M | $26M | $18M | $13M | $36M | $29M | $22M | $16M | $11M | |
| Goodwill | $113M | $107M | $127M | $126M | $131M | $135M | $51M | $52M | $54M | $52M | $53M | $55M | |
| Intangibles | · | · | · | · | $5M | $6M | $6M | $7M | $8M | $9M | $11M | $13M | |
| Other Non-current Assets | $17M | $24M | $35M | $28M | $24M | $13M | $7M | $810.0K | $869.0K | $799.0K | $159.0K | $918.0K | |
| Total Assets | $1.18B | $1.56B | $1.80B | $2.26B | $2.58B | $1.58B | $173M | $208M | $302M | $394M | $386M | $276M | |
| Accounts Payable | $25M | $42M | $133M | $217M | $127M | $54M | $3M | $9M | $6M | $6M | $12M | $13M | |
| Accrued Liabilities | $107M | $211M | $395M | $591M | $674M | $137M | $15M | $20M | $30M | $25M | $27M | $19M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $0 | $395.0K | $603.0K | |
| Current Liabilities | $460M | $1.15B | $1.64B | $2.46B | $2.39B | $580M | $26M | $46M | $74M | $66M | $76M | $34M | |
| Capital Leases | $19M | $23M | $29M | $50M | $39M | $10M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $239M | $360M | $33M | $56M | $42M | $13M | $13M | $9M | $10M | $15M | $13M | $2M | |
| Total Liabilities | $1.30B | $2.18B | $2.51B | $2.89B | $2.93B | $955M | $359M | $376M | $404M | $400M | $93M | $46M | |
| Long-term Debt | $244M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | $0 | $395.0K | $603.0K | |
| Common Stock | $2M | $2M | $1M | $868.0K | $764.0K | $714.0K | $324.0K | $192.0K | $3M | $3M | $3M | $2M | |
| Paid-in Capital | $4.54B | $4.50B | $4.19B | $3.74B | $3.35B | $2.54B | $1.26B | $1.14B | $1.02B | $936M | $952M | $729M | |
| Retained Earnings | $-4.57B | $-5.01B | $-4.82B | $-4.28B | $-3.62B | $-1.87B | $-1.43B | $-1.30B | $-1.11B | $-930M | $-650M | $-493M | |
| Treasury Stock | $103M | $96M | $92M | $91M | $85M | $42M | $3M | $2M | $2M | $2M | $2M | $2M | |
| AOCI | $2M | $-23M | $3M | $-6M | $-1M | $7M | $-13M | $-11M | $-9M | $-12M | $-9M | $-7M | |
| Stockholders' Equity | $-128M | $-624M | $-717M | $-634M | $-352M | $627M | $-186M | $-168M | $-102M | $-6M | $293M | $230M | |
| Liabilities + Equity | $1.18B | $1.56B | $1.80B | $2.26B | $2.58B | $1.58B | $173M | $208M | $302M | $394M | $386M | $276M | |
| Shares Outstanding | 162,575,937 | 161,942,677 | 140,506,093 | 86,806,554 | 76,433,151 | 71,350,365 | 32,352,416 | 19,222,410 | 323,229,390 | 271,245,967 | 269,971,232 | 238,831,864 |
现金流 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $28M | $48M | $41M | $29M | $13M | $4M | $5M | $7M | $8M | $8M | $5M | $4M | |
| Stock-based Comp | $36M | $48M | $85M | $130M | $184M | $128M | $17M | $18M | $20M | $19M | $13M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Amort. of Intangibles | · | · | · | · | $400.0K | $600.0K | $700.0K | $700.0K | $2M | $800.0K | $900.0K | $1M | |
| Restructuring | · | · | $15M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-749M | $4M | $-295M | $83M | $1.87B | · | · | · | $18M | $-3M | $11M | $5M | |
| Operating Cash Flow | $-245M | $-87M | $-714M | $-416M | $323M | $-43M | $-137M | $-185M | $-144M | $-259M | $-126M | $-67M | |
| CapEx | · | · | · | · | $57M | $55M | $2M | $1M | $4M | $18M | $18M | $7M | |
| Investing Cash Flow | $-78M | $-204M | $-59M | $-93M | $100M | $-378M | $38M | $29M | $36M | $28M | $-21M | · | |
| Stock Issued | $0 | $263M | $360M | $249M | $565M | $876M | $97M | $100M | $63M | $0 | $204M | $108M | |
| Net Stock Activity | $0 | $263M | $360M | $249M | $565M | · | · | · | $63M | $0 | $204M | $108M | |
| Financing Cash Flow | $28M | $261M | $4M | $325M | $462M | $985M | $98M | $103M | $65M | $280M | $208M | · | |
| Net Change in Cash | $-289M | $-39M | $-765M | $-179M | $880M | $567M | $221.0K | $-53M | $-44M | $49M | $61M | $-87M | |
| Taxes Paid | $9M | $949.0K | $190.0K | $18M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $265M | · | · | · | $-143M | $-274M | $-144M | $-74M | |
| Levered FCF | · | · | · | · | $244M | · | · | · | · | · | $-145M | $-74M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 40.3% | -36.5% | -57.6% | -32.5% | -147.1% | · | · | · | -550.8% | -1752.8% | -433.8% | -273.0% | |
| Net Margin | 39.2% | -27.5% | -55.4% | -33.2% | -152.1% | · | · | · | -589.5% | -1823.5% | -432.9% | -270.5% | |
| Pretax Margin | 39.4% | -25.9% | -55.2% | -33.0% | -149.6% | · | · | · | · | · | -432.9% | -270.5% | |
| EBITDA Margin | 42.8% | -29.5% | -53.4% | -31.1% | -146.0% | · | · | · | -526.4% | -1697.5% | -417.2% | -258.6% | |
| ROA | 32.2% | -11.2% | -26.9% | -27.2% | -83.9% | · | · | · | -52.8% | -71.8% | -47.4% | -32.5% | |
| ROE | -977.1% | 32.6% | 78.1% | 109.7% | -3180.2% | · | · | · | 342.6% | -195.0% | -60.1% | -38.3% | |
| ROIC | -352.9% | 42.4% | 79.3% | 102.4% | 487.8% | · | · | · | · | · | -53.6% | -36.4% |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.0 | 0.7 | 0.7 | 0.9 | · | · | · | 2.8 | 4.3 | 3.8 | 5.5 | |
| Quick Ratio | 1.6 | 0.8 | 0.3 | 0.5 | 0.8 | · | · | · | 2.1 | 3.5 | 3.0 | 5.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | |
| Interest Coverage | · | · | -39.3 | -32.4 | -79.8 | · | · | · | -12.2 | -20.8 | -652.4 | -533.1 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.4 | 0.5 | 0.8 | 0.6 | · | · | · | 0.1 | 0.0 | 0.1 | 0.1 | |
| Inventory Turnover | 7.2 | 8.0 | 8.8 | 39.6 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | · | · | 3.2 | · | · | · | · | 12.0 | 8.1 | 6.5 |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 64.7% | -30.6% | -50.4% | 72.9% | 141.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -17.2% | -15.9% | 27.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.8% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $682M | $984M | $1.98B | $1.15B | $476M | $19M | $34M | $31M | $15M | $36M | $31M | |
| Net Income TTM | $440M | $-187M | $-545M | $-658M | $-1.74B | $-418M | $-133M | $-185M | $-184M | $-280M | $-157M | $-83M | |
| Market Cap | $1.09B | $1.29B | $670M | $884M | $10.85B | · | · | · | $8.02B | $6.84B | $45.30B | $28.33B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $6.60B | $45.07B | $28.16B | |
| P/E | 2.6 | -6.5 | -0.9 | -1.2 | -6.1 | -15.3 | -0.7 | · | · | · | · | · | |
| P/S | 1.0 | 1.9 | 0.7 | 0.4 | 9.5 | · | · | · | 257.1 | 445.2 | 1249.7 | 923.9 | |
| P/B | -8.6 | -2.1 | -0.9 | -1.4 | -30.9 | · | · | · | -78.8 | -1232.5 | 154.8 | 123.4 | |
| P / Tangible Book | · | · | · | · | · | 16.3 | · | · | · | · | · | · | |
| P / Cash Flow | -4.5 | -14.8 | -0.9 | -2.1 | 33.6 | · | · | · | -57.8 | -26.8 | -359.3 | -422.7 | |
| P / FCF | · | · | · | · | 40.9 | · | · | · | -56.1 | -25.0 | -313.8 | -381.3 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | -25.3 | -298.0 | -355.1 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -24.1 | -312.2 | -379.1 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 429.9 | 1243.3 | 918.4 | |
| Earnings Yield | 38.4% | -15.3% | -112.7% | -81.9% | -16.4% | -6.5% | -138.4% | · | · | · | · | · |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57M | $140M | $147M | $70M | $239M | $667M | $88M | $85M | $415M | $94M | $291M | $187M | $424M | $81M | $357M | $735M | |
| Cost of Revenue | $14M | $31M | $22M | $21M | $15M | $14M | $37M | $61M | $46M | $59M | $155M | $99M | $56M | $34M | $182M | $435M | |
| R&D Expense | $71M | $95M | $76M | $98M | $79M | $89M | $104M | $87M | $107M | $93M | $165M | $106M | $219M | $247M | $258M | $304M | |
| SG&A Expense | $27M | $29M | $34M | $32M | $44M | $48M | $78M | $71M | $101M | $87M | $155M | $107M | $94M | $113M | $162M | $123M | |
| Operating Expenses | $112M | $155M | $133M | $248M | $138M | $151M | $219M | $219M | $254M | $239M | $475M | $313M | $369M | $394M | $601M | $862M | |
| Operating Income | $-55M | $-15M | $14M | $-178M | $101M | $516M | $-131M | $-134M | $161M | $-145M | $-184M | $-126M | $55M | $-313M | $-244M | $-127M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $3M | $4M | · | $4M | |
| Interest Income | $7M | $7M | $7M | $7M | $7M | $8M | $9M | $12M | $9M | · | · | · | · | · | · | · | |
| Other Non-op | $9M | $12M | $9M | $9M | $12M | $10M | $13M | $16M | $8M | $4M | $11M | $-3M | $6M | $24M | $64M | $-35M | |
| Pretax Income | $-52M | $-9M | $18M | $-203M | $107M | $520M | $-74M | $-122M | $165M | $-145M | $-177M | $-131M | $58M | $-293M | $-185M | $-166M | |
| Income Tax | $2M | $985.0K | $376.0K | $-657.0K | $946.0K | $1M | $7M | $-1M | $2M | $2M | $2M | $-697.0K | $-143.0K | $1M | $-2M | $2M | |
| Net Income | $-53M | $-9M | $18M | $-202M | $107M | $519M | $-81M | $-121M | $162M | $-148M | $-178M | $-131M | $58M | $-294M | $-182M | $-169M | |
| EPS (Basic) | $-0.32 | $-0.06 | $0.09 | $-1.25 | $0.66 | $3.22 | $-0.51 | $-0.76 | $1.09 | $-1.05 | $-1.39 | $-1.26 | $0.65 | $-3.41 | $-2.40 | $-2.15 | |
| EPS (Diluted) | $-0.32 | $-0.06 | $0.28 | $-1.25 | $0.62 | $2.93 | $-0.41 | $-0.76 | $0.99 | $-1.05 | $-1.32 | $-1.26 | $0.58 | $-3.41 | $-2.30 | $-2.15 | |
| Shares (Basic) | 164,574,000 | 163,276,000 | -323,430,000 | 162,353,000 | 162,019,000 | 161,049,000 | -296,154,000 | 160,049,000 | 148,379,000 | 139,916,000 | -178,181,000 | 103,429,000 | 89,362,000 | 86,158,000 | -154,691,000 | 78,274,000 | |
| Shares (Diluted) | 164,574,000 | 163,276,000 | -344,090,000 | 162,353,000 | 177,215,000 | 177,625,000 | -313,630,000 | 160,049,000 | 165,855,000 | 139,916,000 | -192,884,000 | 103,429,000 | 104,065,000 | 86,158,000 | -158,945,000 | 78,274,000 | |
| EBITDA | $-55M | $-15M | · | $-178M | $101M | $516M | · | $-134M | $161M | $-145M | · | $-126M | $55M | $-313M | · | $-127M |
资产负债表 29
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $191M | $228M | $241M | $268M | $254M | $263M | $530M | $574M | $680M | $481M | $569M | $651M | $506M | $625M | $1.34B | $1.28B | |
| Short-term Investments | $528M | $562M | $494M | $495M | $359M | $468M | $393M | $336M | $369M | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $112M | |
| Inventory | $10M | $11M | $12M | $14M | $10M | $10M | $9M | $9M | $9M | $16M | · | $70M | $23M | $34M | · | $82M | |
| Prepaid Expense | $23M | $26M | $27M | $46M | $60M | $71M | $78M | $80M | $102M | $199M | · | $152M | $193M | $189M | · | $275M | |
| Other Current Assets | · | · | $10M | · | · | · | $22M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $771M | $851M | $978M | $975M | $920M | $868M | $1.13B | $1.10B | $1.20B | $727M | · | $1.01B | $1.13B | $971M | · | $1.76B | |
| PP&E (Net) | $38M | $42M | $45M | $49M | $130M | $134M | $138M | $286M | $289M | $291M | · | $301M | $300M | $307M | · | $256M | |
| PP&E (Gross) | · | · | $85M | · | · | · | $188M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $41M | · | · | · | $49M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $113M | $113M | $113M | $113M | $113M | $112M | $107M | $127M | $123M | $123M | $127M | $124M | $128M | $130M | $126M | $118M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $8M | |
| Other Non-current Assets | $14M | $16M | $17M | $19M | $21M | $22M | $24M | $31M | $34M | $31M | · | $35M | $33M | $31M | · | $17M | |
| Total Assets | $956M | $1.04B | $1.18B | $1.18B | $1.34B | $1.29B | $1.56B | $1.71B | $1.82B | $1.35B | · | $1.66B | $1.69B | $1.54B | · | $2.27B | |
| Accounts Payable | $23M | $16M | $25M | $15M | $51M | $34M | $42M | $58M | $80M | $58M | · | $102M | $87M | $125M | · | $145M | |
| Accrued Liabilities | $81M | $103M | $107M | $116M | $87M | $132M | $211M | $219M | $159M | $257M | · | $311M | $458M | $519M | · | $551M | |
| Current Liabilities | $331M | $342M | $460M | $430M | $389M | $422M | $1.15B | $1.18B | $1.16B | $804M | · | $1.47B | $1.60B | $1.92B | · | $1.67B | |
| Capital Leases | · | · | $19M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $166M | $193M | $239M | $263M | $288M | $314M | $360M | $319M | $335M | $352M | · | $37M | $38M | $48M | · | $99M | |
| Total Liabilities | $1.15B | $1.19B | $1.30B | $1.34B | $1.30B | $1.37B | $2.18B | $2.24B | $2.25B | $2.22B | · | $2.34B | $2.44B | $2.44B | · | $2.83B | |
| Long-term Debt | $291M | $291M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $952.0K | $871.0K | · | $792.0K | |
| Paid-in Capital | $4.56B | $4.55B | $4.54B | $4.53B | $4.52B | $4.51B | $4.50B | $4.49B | $4.48B | $4.20B | · | $4.07B | $3.86B | $3.77B | · | $3.64B | |
| Retained Earnings | $-4.63B | $-4.58B | $-4.57B | $-4.59B | $-4.38B | $-4.49B | $-5.01B | $-4.93B | $-4.81B | $-4.97B | · | $-4.64B | $-4.51B | $-4.57B | · | $-4.09B | |
| Treasury Stock | $112M | $112M | $103M | $103M | $102M | $102M | $96M | $95M | $94M | $94M | · | $92M | $91M | $91M | · | $90M | |
| AOCI | $-7M | $-5M | $2M | $-2M | $-458.0K | $2M | $-23M | $4M | $-11M | $-11M | · | $-12M | $-8M | $-3M | · | $-24M | |
| Stockholders' Equity | $-191M | $-145M | $-128M | $-157M | $38M | $-76M | $-624M | $-526M | $-432M | $-867M | $-717M | $-678M | $-755M | $-896M | $-634M | $-566M | |
| Liabilities + Equity | $956M | $1.04B | $1.18B | $1.18B | $1.34B | $1.29B | $1.56B | $1.71B | $1.82B | $1.35B | · | $1.66B | $1.69B | $1.54B | · | $2.27B | |
| Shares Outstanding | 164,815,529 | 164,422,575 | 162,575,937 | 162,470,138 | 162,155,109 | 161,957,868 | 160,421,136 | 160,148,088 | 159,891,014 | 140,373,255 | 140,506,093 | 118,730,398 | 94,308,379 | 86,291,473 | 86,806,554 | 78,476,814 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $5M | $7M | $8M | $8M | $13M | $13M | $11M | $12M | $11M | $11M | $10M | $9M | $7M | $8M | |
| Stock-based Comp | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $12M | $14M | $12M | $16M | $21M | $20M | $29M | $28M | $32M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $400.0K | |
| Restructuring | · | · | · | · | · | $500.0K | · | · | $1M | $6M | · | $-140.0K | $15M | · | · | · | |
| Operating Cash Flow | $-73M | $-32M | $-39M | $108M | $-127M | $-186M | $-173M | $-145M | $314M | $-84M | $-177M | $-40M | $-172M | $-326M | $-118M | $-39M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | |
| Investing Cash Flow | $35M | $-28M | $20M | $-137M | $111M | $-73M | $144M | $32M | $-373M | $-7M | $-9M | $-18M | $-8M | $-24M | $-22M | $-30M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $256M | $7M | $103M | $195M | $62M | $0 | $70M | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $7M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $38M | $-7M | $42M | $-1M | $-7M | $-3M | $-97.0K | $258M | $6M | $100M | $197M | $61M | $-354M | $191M | $-31M | |
| Net Change in Cash | $-37M | $-23M | $-27M | $14M | $-9M | $-267M | $-43M | $-107M | $200M | $-88M | $-83M | $148M | $-119M | $-712M | $56M | $-94M | |
| Taxes Paid | $985.0K | $2M | $6.0K | $4M | $3M | $1M | $308.0K | $1M | $-578.0K | $-71.0K | $62.0K | $0 | $128.0K | $0 | $137.0K | $65.0K |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -96.8% | -11.1% | · | -252.7% | 42.2% | 77.3% | · | -158.6% | 38.8% | -154.3% | · | -67.2% | 13.1% | -386.4% | · | -17.3% | |
| Net Margin | -94.2% | -6.8% | · | -287.3% | 44.5% | 77.8% | · | -143.5% | 39.1% | -157.2% | · | -69.9% | 13.7% | -363.1% | · | -22.9% | |
| Pretax Margin | -91.1% | -6.1% | · | -288.2% | 44.9% | 78.0% | · | -144.8% | 39.6% | -154.8% | · | -70.3% | 13.6% | -361.6% | · | -22.6% | |
| EBITDA Margin | -96.8% | -11.1% | · | -252.7% | 42.2% | 77.3% | · | -158.6% | 38.8% | -154.3% | · | -67.2% | 13.1% | -386.4% | · | -17.3% | |
| ROA | -4.7% | -0.81% | · | -14.0% | 6.8% | 39.2% | · | -7.2% | 9.3% | -10.2% | · | -6.7% | 2.7% | -13.4% | · | -7.0% | |
| ROE | 69.8% | 8.6% | · | 59.2% | -54.0% | -110.0% | · | 20.1% | -27.4% | 16.7% | · | 21.0% | -9.9% | 70.8% | · | 322.2% | |
| ROIC | 29.7% | 11.9% | · | 113.3% | 266.3% | -679.9% | · | 25.2% | -36.8% | 17.0% | · | 18.4% | -7.4% | 35.1% | · | 22.8% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.5 | · | 2.3 | 2.4 | 2.1 | · | 0.9 | 1.0 | 0.9 | · | 0.7 | 0.7 | 0.5 | · | 1.1 | |
| Quick Ratio | 2.2 | 2.3 | · | 1.8 | 1.6 | 1.7 | · | 0.8 | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.3 | · | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.2 | · | -43.9 | 17.8 | -72.5 | · | -30.5 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.0 | 0.2 | 0.5 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.0 | · | 0.3 | |
| Inventory Turnover | 1.4 | 2.8 | · | 1.9 | 1.6 | 1.1 | · | 1.5 | 2.8 | 2.4 | · | 1.3 | 0.4 | 0.5 | · | 10.5 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 7.9 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $506M | $1.12B | · | $1.06B | $1.41B | $1.26B | · | $781M | $1.12B | $786M | · | $1.43B | $1.43B | $1.71B | · | $1.80B | |
| Net Income TTM | $-159M | $413M | · | $301M | $666M | $412M | · | $-237M | $-58M | $-514M | · | $-535M | $-915M | $-770M | · | $-798M | |
| Market Cap | $1.55B | $1.34B | · | $1.41B | $1.02B | $1.04B | · | $2.02B | $2.02B | $671M | · | $860M | $701M | $598M | · | $1.43B | |
| P/E | -9.3 | 3.6 | · | 5.6 | 1.7 | 3.0 | · | -6.1 | -17.1 | -0.9 | · | -1.2 | -0.6 | -0.7 | · | -1.7 | |
| P/S | 3.1 | 1.2 | · | 1.3 | 0.7 | 0.8 | · | 2.6 | 1.8 | 0.9 | · | 0.6 | 0.5 | 0.4 | · | 0.8 | |
| P/B | -8.1 | -9.2 | · | -9.0 | 27.2 | -13.7 | · | -3.8 | -4.7 | -0.8 | · | -1.3 | -0.9 | -0.7 | · | -2.5 | |
| P / Cash Flow | · | -41.3 | · | · | · | -5.6 | · | · | · | -8.0 | · | · | · | -1.8 | · | · | |
| Earnings Yield | -10.7% | 27.5% | · | 17.8% | 60.0% | 32.9% | · | -16.5% | -5.9% | -107.5% | · | -86.2% | -154.9% | -137.5% | · | -57.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $1.12B | $682M | $984M | $1.98B | $1.15B |
| 营业利润率 % | 40.3% | -36.5% | -57.6% | -32.5% | -147.1% |
| 净收入 | $440M | $-187M | $-545M | $-658M | $-1.74B |
| 稀释后每股收益 (EPS) | $2.58 | $-1.23 | $-5.41 | $-8.42 | $-23.44 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 2.1 | 1.0 | 0.7 | 0.7 | 0.9 |
| 速动比率 | 1.6 | 0.8 | 0.3 | 0.5 | 0.8 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | — | — | — | $265M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 317 家申报者 · $957.7M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 52 (-8 与上一季度对比) | 28 (-3 与上一季度对比) | 78 (+7 与上一季度对比) | 91 (+7 与上一季度对比) | +2.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| SHAH CAPITAL MANAGEMENT | $133439735 | 14165577 | 13.93% | 股份 |
| STATE STREET CORP | $110595981 | 11740550 | 11.55% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $71667322 | 7607996 | 7.48% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $68365170 | 7257449 | 7.14% | 股份 |
| Sanofi | $64814131 | 6880481 | 6.77% | 股份 |
| D. E. Shaw & Co., Inc. | $50136763 | 5322374 | 5.24% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $38537625 | 4091043 | 4.02% | 股份 |
| COATUE MANAGEMENT LLC | $36144408 | 3836986 | 3.77% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $34061945 | 3615026 | 3.56% | 股份 |
| BANK OF AMERICA CORP /DE/ | $24233016 | 2572507 | 2.53% | 股份 |
| Graham Capital Management, L.P. | $19655772 | 2086600 | 2.05% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18572472 | 1971600 | 1.94% | 买入期权 |
| GOLDMAN SACHS GROUP INC | $18054901 | 1916656 | 1.89% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $16656095 | 1768163 | 1.74% | 股份 |
| CITADEL ADVISORS LLC | $15409236 | 1635800 | 1.61% | 卖出期权 |
| Allianz Asset Management GmbH | $14876064 | 1579200 | 1.55% | 股份 |
| TSP Capital Management Group, LLC | $13370420 | 1419365 | 1.40% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $12685038 | 1346607 | 1.32% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $10221642 | 1085100 | 1.07% | 股份 |
| JUPITER ASSET MANAGEMENT LTD | $10081585 | 1070232 | 1.05% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8604228 | 913400 | 0.90% | 卖出期权 |
| Point72 Asset Management, L.P. | $6257574 | 664286 | 0.65% | 股份 |
| FMR LLC | $5726710 | 607931 | 0.60% | 股份 |
| Monaco Asset Management SAM | $5439711 | 577464 | 0.57% | 股份 |
| Bank of New York Mellon Corp | $5355600 | 568535 | 0.56% | 股份 |
| Edgestream Partners, L.P. | $5273278 | 559796 | 0.55% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4767302 | 506083 | 0.50% | 股份 |
| CITIGROUP INC | $4751457 | 504401 | 0.50% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $4726796 | 501783 | 0.49% | 股份 |
| CITADEL ADVISORS LLC | $4518774 | 479700 | 0.47% | 买入期权 |
| CITIGROUP INC | $4443414 | 471700 | 0.46% | 买入期权 |
| Trexquant Investment LP | $4349610 | 461742 | 0.45% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $4115598 | 436900 | 0.43% | 买入期权 |
| FIRST TRUST ADVISORS LP | $3633284 | 385699 | 0.38% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $3625108 | 384831 | 0.38% | 股份 |
| UBS Group AG | $3499643 | 371512 | 0.37% | 买入期权 |
| JANE STREET GROUP, LLC | $2700714 | 286700 | 0.28% | 买入期权 |
| GROUP ONE TRADING LLC | $2673594 | 283821 | 0.28% | 股份 |
| ALGERT GLOBAL LLC | $2618666 | 277990 | 0.27% | 股份 |
| Swiss National Bank | $2617818 | 277900 | 0.27% | 股份 |
| Quantinno Capital Management LP | $2231683 | 236909 | 0.23% | 股份 |
| D. E. Shaw & Co., Inc. | $2176020 | 231000 | 0.23% | 买入期权 |
| Rafferty Asset Management, LLC | $1965916 | 208696 | 0.21% | 股份 |
| RHUMBLINE ADVISERS | $1927930 | 204665 | 0.20% | 股份 |
| Cubist Systematic Strategies, LLC | $1920763 | 221540 | 0.20% | 股份 |
| WOLVERINE ASSET MANAGEMENT LLC | $1853856 | 196800 | 0.19% | 卖出期权 |
| Schonfeld Strategic Advisors LLC | $1832819 | 194567 | 0.19% | 股份 |
| Headlands Technologies LLC | $1794953 | 190547 | 0.19% | 股份 |
| GOLDMAN SACHS GROUP INC | $1769076 | 187800 | 0.18% | 买入期权 |
| GOLDMAN SACHS GROUP INC | $1765308 | 187400 | 0.18% | 卖出期权 |
| Walleye Trading LLC | $1764366 | 187300 | 0.18% | 卖出期权 |
| XTX Topco Ltd | $1574704 | 167166 | 0.16% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1519233 | 186638 | 0.16% | 股份 |
| DEUTSCHE BANK AG\ | $1489556 | 158127 | 0.16% | 股份 |
| Aquatic Capital Management LLC | $1447524 | 153665 | 0.15% | 股份 |
| D. E. Shaw & Co., Inc. | $1413000 | 150000 | 0.15% | 卖出期权 |
| NOMURA HOLDINGS INC | $1413000 | 150000 | 0.15% | 买入期权 |
| ALLIANCEBERNSTEIN L.P. | $1307308 | 160603 | 0.14% | 股份 |
| BARCLAYS PLC | $1287525 | 136680 | 0.13% | 股份 |
| BlackRock, Inc. | $1283965 | 136302 | 0.13% | 股份 |
| Squarepoint Ops LLC | $1258154 | 133562 | 0.13% | 股份 |
| Virtus Investment Advisers, LLC | $1233596 | 130955 | 0.13% | 股份 |
| MORGAN STANLEY | $1224214 | 129959 | 0.13% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $1181909 | 125468 | 0.12% | 股份 |
| JANE STREET GROUP, LLC | $1170906 | 124300 | 0.12% | 卖出期权 |
| PROFUND ADVISORS LLC | $986142 | 104686 | 0.10% | 股份 |
| IEQ CAPITAL, LLC | $954765 | 101355 | 0.10% | 股份 |
| NewEdge Wealth, LLC | $947266 | 100559 | 0.10% | 股份 |
| Caption Management, LLC | $942000 | 100000 | 0.10% | 卖出期权 |
| Point72 Asset Management, L.P. | $942000 | 100000 | 0.10% | 买入期权 |
| NOMURA HOLDINGS INC | $942000 | 100000 | 0.10% | 卖出期权 |
| Sculptor Capital LP | $936348 | 99400 | 0.10% | 卖出期权 |
| Nebula Research & Development LLC | $923126 | 146528 | 0.10% | 股份 |
| OPPENHEIMER & CO INC | $892630 | 94759 | 0.09% | 股份 |
| Palumbo Wealth Management LLC | $875561 | 92947 | 0.09% | 股份 |
| MetLife Investment Management, LLC | $838804 | 89045 | 0.09% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $832992 | 88428 | 0.09% | 股份 |
| Cubist Systematic Strategies, LLC | $814980 | 94000 | 0.09% | 买入期权 |
| MARTINGALE ASSET MANAGEMENT L P | $806079 | 85571 | 0.08% | 股份 |
| Balyasny Asset Management L.P. | $774701 | 82240 | 0.08% | 股份 |
| Walleye Trading LLC | $760194 | 80700 | 0.08% | 买入期权 |
| Ares Systematic Credit Ltd | $755060 | 80155 | 0.08% | 股份 |
| Walleye Trading LLC | $717710 | 76190 | 0.07% | 股份 |
| Brevan Howard Capital Management LP | $657657 | 69815 | 0.07% | 股份 |
| AXQ CAPITAL, LP | $645082 | 68480 | 0.07% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $614203 | 65202 | 0.06% | 股份 |
| Vanguard Global Advisers, LLC | $602268 | 63935 | 0.06% | 股份 |
| OP Asset Management Ltd | $597200 | 63397 | 0.06% | 股份 |
| Mariner, LLC | $596910 | 63368 | 0.06% | 股份 |
| VANGUARD GROUP INC | $594236 | 88428 | 0.06% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $581402 | 61720 | 0.06% | 股份 |
| Vontobel Holding Ltd. | $563928 | 59865 | 0.06% | 股份 |
| Invesco Ltd. | $560980 | 59552 | 0.06% | 股份 |
| Cubist Systematic Strategies, LLC | $557481 | 64300 | 0.06% | 卖出期权 |
| STRS OHIO | $547302 | 58100 | 0.06% | 股份 |
| NOMURA HOLDINGS INC | $524534 | 55683 | 0.05% | 股份 |
| COMMONWEALTH EQUITY SERVICES, LLC | $518619 | 55055 | 0.05% | 股份 |
| Quadrature Capital Ltd | $507653 | 53891 | 0.05% | 股份 |
| JANUS HENDERSON GROUP PLC | $495946 | 60815 | 0.05% | 股份 |
| BANK OF MONTREAL /CAN/ | $479478 | 50900 | 0.05% | 卖出期权 |
公司内部人士 52 位内幕人士 · 27 位高管 · 25 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| John C Jacobs | President and CEO | 2026年3月2日 A | 225680 | 0 | 0 | $0 |
| Stanley C Erck | President and CEO | 2022年12月14日 M | 36492 | 0 | 0 | $0 |
| Rahul Singhvi | President, CEO | 2011年3月10日 A | 113104 | 0 | 0 | $0 |
| James Patrick Kelly | EVP, CFO and Treasurer | 2026年3月7日 M | 130599 | 0 | 0 | $0 |
| Gregory F Covino | EVP, Chief Financial Officer | 2020年11月16日 A | — | 0 | 0 | $0 |
| Barclay A Phillips | SVP, Chief Financial Officer | 2017年7月31日 P | 38669 | 0 | 0 | $0 |
| Frederick W Driscoll | VP, CFO & Treasurer | 2013年3月2日 A | 20000 | 0 | 0 | $0 |
| Len F Stigliano | VP, CFO, Treasurer | 2008年7月31日 P | 20554 | 0 | 0 | $0 |
| Jeffrey Wayne Church | VP, CFO, Treasurer & Corp. Sec | 2007年3月7日 A | — | 0 | 0 | $0 |
| Dennis W Genge | VP, Treasurer,CFO | 2006年2月17日 A | 6400 | 0 | 0 | $0 |
| Filip Dubovsky | President, R&D | 2024年5月14日 M | 38953 | 0 | 0 | $0 |
| Gregory M Glenn | President, R&D | 2023年3月10日 M | 18339 | 0 | 0 | $0 |
| Robert Edward Walker | EVP, R&D | 2026年4月14日 A | — | 0 | 0 | $0 |
| Ruxandra Draghia-Akli | EVP, Research & Development | 2026年3月2日 A | 23563 | 0 | 0 | $0 |
| Elaine O'Hara | EVP, Chief Strategy Officer | 2026年3月2日 A | 134642 | 0 | 0 | $0 |
| Mark J Casey | EVP, Chief Legal Officer | 2026年3月2日 A | 90067 | 0 | 0 | $0 |
| John Trizzino | EVP, CCO and CBO | 2024年3月1日 A | 27972 | 0 | 0 | $0 |
| John A Herrmann III | EVP, Chief Legal Officer | 2023年12月14日 M | 13233 | 0 | 0 | $0 |
| Timothy Jon Hahn | SVP, Manufacturing | 2015年3月5日 A | 110485 | 0 | 0 | $0 |
| Wilson Russell P | SVP, Business Development | 2015年3月5日 A | 64939 | 0 | 0 | $0 |
| Thomas Scott Johnston | Vice President, Strategy | 2010年3月15日 A | 11000 | 0 | 0 | $0 |
| Penny Heaton | VP & Chief Medical Officer | 2009年7月2日 S | 18667 | 0 | 0 | $0 |
| Evdoxia E Kopsidas | Sr.Dir.Fin.,Prin.Acctg.Officer | 2009年6月17日 A | — | 0 | 0 | $0 |
| Jim Robinson | VP, Technical & Quality Ops. | 2009年3月5日 A | 77590 | 0 | 0 | $0 |
| Hall Patricia | Chief Accounting Officer | 2006年10月31日 M | 13514 | 0 | 0 | $0 |
| Ford R Lynch | Sr. VP Marketing and Sales | 2004年7月26日 P | 4300 | 0 | 0 | $0 |
| Craig D Wright | Chief Scientific Officer | 2004年3月9日 A | 51626 | 0 | 0 | $0 |
| Rachel K. King | 董事 | 2026年6月20日 M | 44070 | 0 | 0 | $0 |
| Gregg H Alton | 董事 | 2026年6月20日 M | 47685 | 0 | 0 | $0 |
| Richard J Rodgers | 董事 | 2026年6月20日 M | 47370 | 0 | 0 | $0 |
| David M Mott | 董事 | 2026年6月20日 M | 79770 | 0 | 0 | $0 |
| Margaret G Mcglynn | 董事 | 2026年6月20日 M | 44468 | 0 | 0 | $0 |
| DOUGLAS RICHARD | 董事 | 2026年6月20日 M | 73220 | 0 | 0 | $0 |
| John W. Shiver | 董事 | 2026年6月18日 A | 7947 | 0 | 0 | $0 |
| Charles W. Newton | 董事 | 2026年6月18日 A | 9520 | 0 | 0 | $0 |
| James F Young | 董事 | 2023年6月12日 A | 68590 | 0 | 0 | $0 |
| Michael A Mcmanus JR | 董事 | 2022年6月16日 M | 10101 | 0 | 0 | $0 |
| Gary C Evans | 董事 | 2021年6月17日 M | 19549 | 0 | 0 | $0 |
| Gail Boudreaux | 董事 | 2017年3月16日 A | 200000 | 0 | 0 | $0 |
| Rajiv I. Modi | 董事 | 2015年6月17日 S | 2500000 | 0 | 0 | $0 |
| John O Marsh JR | 董事 | 2014年3月6日 A | 36000 | 0 | 0 | $0 |
| John A Lambert | 董事 | 2010年4月15日 A | 80000 | 0 | 0 | $0 |
| Thomas P Monath | 董事 | 2009年3月5日 A | 3225366 | 0 | 0 | $0 |
| James B Tananbaum | 董事 | 2009年3月5日 A | 3151818 | 0 | 0 | $0 |
| ODONNELL DENIS M | 董事 | 2007年3月7日 A | 221495 | 0 | 0 | $0 |
| KELLY MITCHELL J | 董事 | 2006年3月3日 S | 500 | 0 | 0 | $0 |
| Michael J Lazarus MD | 董事 | 2006年2月17日 A | 11927 | 0 | 0 | $0 |
| Susan B Bayh | 董事 | 2005年5月4日 A | — | 0 | 0 | $0 |
| Ronlad H Walker | 董事 | 2004年3月9日 A | — | 0 | 0 | $0 |
| KING PHARMACEUTICALS INC | 10% 所有者 | 2004年7月16日 J | 4100931 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 11 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Shah Capital Management, Shah Capital Opportunity Fund LP, Himanshu H. Shah ×7 申报 | 2026年5月15日 | 9.03% | 修订 | — | SEC |
| Shah Capital Management, Inc., Shah Capital Opportunity Fund LP, Himanshu H. Shah ×2 申报 | 2024年5月20日 | — | 初始申报 | — | SEC |
| Dr. Rajiv I. Modi, Cadila Pharmaceuticals Ltd, Satellite Overseas (Holdings) Limited ×3 申报 | 2014年3月21日 | — | 初始申报 | — | SEC |
| KPCB Holdings, Inc., KPCB Pandemic and Bio Defense Fund, LLC, KPCB PBD Associates, LLC | 2006年3月10日 | — | 初始申报 | 被动投资 | SEC |
| 未披露的报告人, 未披露的报告人 | 2005年11月4日 | — | 初始申报 | — | SEC |
| King Pharmaceuticals, Inc. ×2 申报 | 2005年10月13日 | — | 初始申报 | — | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2005年9月6日 | — | 初始申报 | 被动投资 | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2003年2月26日 | — | 初始申报 | 被动投资 | SEC |
| S.S. or King Pharmaceuticals, Inc. | 2002年7月24日 | — | 初始申报 | 被动投资 | SEC |
| 未披露的报告人 | 2001年9月19日 | — | 初始申报 | 被动投资 | SEC |
| Anaconda Opportunity Fund, L.P., Anaconda Capital, L.P., Mitchell J. Kelly ×2 申报 | 2001年4月10日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 44 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.93% | 144044 NS | 2026年4月30日 | N-PORT |
| SBIO · ALPS ETF Trust | 1.14% | 167949 NS | 2026年5月31日 | N-PORT |
| FYT · First Trust Exchange-Traded Alpha... | 0.46% | 107393 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.41% | 267379 NS | 2026年4月30日 | N-PORT |
| BFOR · ALPS ETF Trust | 0.25% | 48103 NS | 2026年5月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.17% | 255864 NS | 2026年4月30日 | N-PORT |
| FAB · First Trust Exchange-Traded Alpha... | 0.09% | 16601 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.09% | 6023 NS | 2026年5月31日 | N-PORT |
| ITWO · ProShares Trust | 0.04% | 7046 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.04% | 785989 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.04% | 64942 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.02% | 5511 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.02% | 5579 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 62651 NS | 2026年4月30日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 25102 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 6647 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 140 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 53436 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 98296 NS | 2026年5月31日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 529 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 228 NS | 2026年4月30日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 2886 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRF · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCG · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCV · iShares Trust | — | — | 2026年8月5日 | 每日 |
| SMLF · iShares Trust | — | — | 2026年8月10日 | 每日 |
| IDNA · iShares Trust | — | — | 2026年8月12日 | 每日 |
| TECB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |